David Dinges, MSc, MA, PhD, is internationally renowned for his extensive studies
of the effects of sleep loss and work hours on the neurobehavioral and physiological
regulation of human performance and health, with a particular emphasis on demanding,
stressful, safety-sensitive settings, such as health care, first responders, transportation,
and spaceflight. David’s transition to Emeritus Professor status at the University
of Pennsylvania in 2021, celebrated at the height of the COVID-19 pandemic by means
of a Zoom videoconference (see Video 1), underscores an illustrious career as a leading
sleep and circadian scientist and a cherished mentor to many in the field. With this
virtual collection of the journal SLEEP Advances, the journal’s editor-in-chief, the
Sleep Research Society, and the authors of this Foreword join forces to celebrate
David’s many milestone contributions to science and to the scientific community—through
the time-tested tradition of a Festschrift, an edited volume honoring a respected
academic, presented during their lifetime, containing contributions from colleagues
and former trainees [1].
David earned his PhD in Experimental Physiological Psychology from Saint Louis University
and, after a brief engagement at George Washington University, joined the Department
of Psychiatry at the University of Pennsylvania, where he was tenured in 1993 and
promoted to full professor in 1998. He has served as principal investigator of many
laboratory and field studies, which were supported by more than 60 federal grants
from the National Aeronautics and Space Administration, the National Institutes of
Health, the US Departments of Defense and Transportation, as well as grants from foundations
and industry. His primary scientific focus has been on identifying how sleep need
and its interaction with circadian biology affect human neurobehavioral functions,
cognitive performance, operational safety, emotional states, stress responses, endocrine,
immune, inflammatory, and metabolic physiology, as well as health.
While it is difficult to choose from David’s extensive publication record (more than
500 papers and chapters to date) for which of his many discoveries, inventions, and
ideas to highlight here, probably the most impactful have resulted from his large
scale, carefully conducted laboratory studies exposing the cumulative effects of sleep
loss on neurobehavioral performance [2–4]. An elegant dose-response study demonstrating
the steady build-up of neurobehavioral impairment across consecutive days of sustained
sleep restriction [3] stands among the most cited publications in sleep science, reflecting
its broad impact on basic and translational sleep science and sleep medicine. Since
its publication 20 years ago, this work has had important implications for basic research,
raising profound questions about sleep need [5], the temporal dynamics of neurobehavioral
functioning [6], and what aspect(s) of sleep provide recuperation [7]. In this Festschrift,
David’s former trainee and colleague Siobhan Banks and one of her own trainees summarize
the current literature on recovery sleep and suggest next steps for research in this
field [8]. Former trainee Janet Mullington, with one of her own trainees and other
colleagues, adds a new dimension to this work by examining the influence of sleep
timing, with a particular focus on mood [9].
David’s research on sustained sleep restriction also has far-reaching implications
for real-world (e.g. operational and clinical) settings, revealing that work schedules
that impinge on time for sleep put people at risk of performance impairment and associated
errors and accidents [10–12]. This issue is especially pressing in operational settings
with little tolerance for error, such as spaceflight—an area in which the contributions
of David’s group [13–16] have been particularly influential. For his outstanding contributions
to research on astronaut behavioral health with a focus on sleep, circadian rhythms,
and neurobehavioral performance, David received NASA’s Distinguished Public Service
Medal, which is NASA’s highest honor awarded to a non-government employee, in 2007,
and the National Space Biomedical Research Institute’s Pioneer Award in 2016.
1
In this Festschrift, David’s former trainee and collaborator Terri Weaver and her
colleagues review the knowledge base on sleep loss and operational performance as
it pertains to astronauts, pilots, and commercial truck drivers [17]. Additionally,
the group of Torbjörn Åkerstedt shows that sleep efficiency, but not total sleep time,
is a predictor of next-day subjective sleepiness in a population-based cohort of women
[18].
With colleagues at the University of Pennsylvania and elsewhere, David has pursued
a line of research focused on inter-individual differences in vulnerability to sleep
loss. After demonstrating that these inter-individual differences constitute a trait
[19], a fruitful search for genetic predictors and other biomarkers ensued [20–22].
Furthermore, David has focused on technological solutions to measure and mitigate
the adverse impact of sleep loss on individuals [23–26]. He has played an important
role in the development of one of the most sensitive tools available to unobtrusively
measure neurobehavioral impairment due to sleep loss: PERCLOS (i.e. percent time of
slow eyelid closures) [27]. In this Festschrift, David’s former trainee Takashi Abe
provides a review of the present state of evidence on PERCLOS [28].
To study the risks posed by sleep loss with precision, David invented the Psychomotor
Vigilance Test (PVT)—a brief (10-min), portable, highly sensitive measure of human
behavioral alertness [29, 30], which requires no learning [31]. What exactly makes
the PVT so exquisitely sensitive to the effects of sleep loss and circadian rhythmicity
has been much investigated and debated [32–37]. David’s influential state instability
hypothesis posits that the PVT captures variability in vigilant attention due to the
effect of sleep-initiating mechanisms on a person’s endogenous capacity to maintain
attention and alertness [32]. Here, David’s former trainee and colleague Hans Van
Dongen and the latter’s own former trainee and colleague Kimberly Honn show that while
bottom-up variability in vigilant attention is a key contributor [38], top-down attentional
control mechanisms also appear to play a role [39].
Colleagues at the Walter Reed Army Institute of Research find that the PVT compares
favorably to other tools traditionally used in the sleep field to measure the effects
of sleep deprivation (i.e. the multiple sleep latency test and the maintenance of
wakefulness test) [40]. Also in this Festschrift, David’s former trainee Julian Lim
and his colleagues show that metrics derived from baseline PVT performance can predict
vulnerability to performance impairment during sustained sleep restriction [41]. Further,
David’s former trainee Daniel Mollicone and his colleagues provide evidence of the
utility and ecological validity of an abbreviated (3-min) version of the PVT as a
fatigue risk management tool in real world, safety-critical operations [42]. And David’s
long-standing colleague Mathias Basner describes the development of an even shorter,
adaptive version of the PVT for use in operational settings where time available for
taking performance measurements is negligible [43].
Keenly aware that humans often incur sleep loss because of competing demands from
work time [44] and social pursuits [45], which puts them at risk of errors and accidents
[46], David has also explored a multitude of potential countermeasures. In addition
to research on the effectiveness of protected time for sleep [47, 48] and rest breaks
[49, 50], his work on nap sleep [32, 51–53] and the associated sleep inertia [54–56]
is particularly well known. Pharmacological countermeasures such as caffeine and modafinil/armodafinil
have been of interest to him as well [57–61]. Moreover, the impressive amounts of
data collected in David’s laboratory have provided a solid foundation for to the development
of a biomathematical model of fatigue and performance [62]—a predictive tool that
is central in modern approaches to fatigue risk management [63, 64]. Through these
and other efforts, David has contributed significantly to policies and practices for
fatigue risk management and safety [65–70].
While neurobehavioral function in all of its facets has been central to many of David’s
laboratory and field studies, he has also investigated the physiological effects of
sleep loss and circadian rhythmicity. This includes studies of metabolism [71, 72],
hormones [73–75], inflammatory markers [76–78], and functional brain activation [79–81].
With colleagues at the University of Pennsylvania, this research has extended to obstructive
sleep apnea [82–84] and other medical disorders.
The prolific research environment of David’s laboratory has been fertile ground for
training and mentoring of students, postdoctoral researchers, and junior faculty.
Over the years, David has mentored hundreds of undergraduate, postbaccalaureate, and
graduate students, as well as dozens of postdocs and faculty. For 26 years, he taught
the hugely popular University of Pennsylvania course “Human Chronobiology and Sleep.”
A gifted speaker, he has delivered more than 800 invited lectures in academic settings
and at scientific meetings. He has also been quite generous with his time for service
to the scientific community, including serving as president of the Sleep Research
Society and the World Sleep Federation, as chair or member of numerous advisory and
review panels, and as editor-in-chief of the journal SLEEP with a 10-year tenure.
David Dinges is a major source of inspiration to the countless individuals who have
worked with him as colleagues and collaborators, government and industry partners,
or trainees and mentees. For a career retrospective, in the form of an interview with
him by Mark Rosekind, see Video 2. It is our hope that this Festschrift stimulates
further research and helps move forward the areas in which David’s work has yielded—and
continues to yield—so many phenomenal discoveries and insights.